Arterial hypertension and dementia;Arterielle hypertonie und demenz

Nervenarzt

Volumn 76, Issue 2, 2005, Pages 143-153

  Scheid, R ^a   Voigt, H ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Clinical trials; Cognition; Dementia; Hypertension

Indexed keywords

AMILORIDE; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CANDESARTAN; CHLORTALIDONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; HYDROCHLOROTHIAZIDE; INDAPAMIDE; NITRENDIPINE; PERINDOPRIL; RAMIPRIL;

ALZHEIMER DISEASE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; COGNITIVE DEFECT; DEMENTIA; DRUG SPECIFICITY; HUMAN; HYPERTENSION; HYPOTENSION; HYPOTHESIS; LONGITUDINAL STUDY; POPULATION RESEARCH; PROSPECTIVE STUDY; REVIEW;

ANTIHYPERTENSIVE AGENTS; CLINICAL TRIALS; DEMENTIA; HYPERTENSION; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES; TREATMENT OUTCOME;

EID: 14544284116     PISSN: 00282804     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00115-004-1787-3     Document Type: Review

References (89)

1. American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders, 3rd edn, revised (DSM-III-R). American Psychiatric Association, Washington DC
2. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn (DSM-IV). American Psychiatric Association, Washington DC
3. Atkinson RC, Shiffrin RM (1971) The control of short-term memory. Sci Am 225:82-90
4. Birkenhäger WH, Forette F, Seux ML et al. (2001) Blood pressure, cognitive functions, and prevention of dementias in older patients with hypertension. Arch Intern Med 161:152-156
5. Blood Pressure Lowering Treatment Trialists' Collaboration (2000) Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Lancet 356:1955-1964
6. Bosch J, Yusuf S, Pogue J et al. (2002) Use of ramipril in preventing stroke: double blind randomised trial. BMJ 324:1-5
7. Brown WR, Moody DM, Thore CR et al. (2000) Cerebrovascular pathology in Alzheimer's disease and leukoaraiosis. Ann NY Acad Sci 903:39-45
8. Clarke CE (1999) Does the treatment of isolated systolic hypertension prevent dementia? J Hum Hypertens 13:357-358
9. Copeland JR, Kelleher MJ, Kellett JM et al. (1976) A semi-structured clinical interview for the assessment of diagnosis and mental state in the elderly: the Geriatric Mental State Schedule. Psychol Med 6:439-494
10. DeCarli C (2003) The role of cerebrovascular disease in dementia. Neurologist 9:123-136
11. de la Torre JC (2004) Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics. Lancet Neurol 3:184-190
12. de Leeuw FE, de Groot JC, Oudkerk M et al. (2002) Hypertension and cerebral white matter lesions in a prospective cohort study. Brain 125:765-772
13. Dettmers C, Hagendorff A, Lüderitz B et al. (1997) Progrediente zerebrale Parenchymschäden durch rezidivierende arterielle Hypotonien. Nervenarzt 68:625-632
14. Deutsche Hochdruckliga/Deutsche Hypertonie Gesellschaft (2002) Empfehlungen zur Hochdruckbehandlung, 17. Aufl. Heidelberg
15. Diener HC, Phillip T, Schrader J (2003) Folgen der Hypertonie am Endorgan Gehirn. Internist 44:786-792
16. Elias MF, Wolf PA, D'Agostino RB et al. (1993) Untreated blood pressure level is inversely related to cognitive functioning: the Framingham Study. Am J Epidemiol 138:353-364
17. Erkinjuntti T (1987) Types of multi-infarct dementia. Acta Neurol Scand 75:391-399
18. Farmer ME, White LR, Kittner SJ et al. (1987) Neuropsychological test performance in Framingham: a descriptive study. Psychol Rep 60:1023-1040
19. Folstein MF, Folstein SE, McHugh PR (1975) 'Mini-mental state': a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189-198
20. Forette F, Seux ML, Staessen JA et al. (1998) Prevention of dementia in randomised double-blind placebo-controlled systolic hypertension in Europe (Syst-Eur) trial. Lancet 352:1347-1351
21. Forette F, Seux ML, Staessen JA et al. (2002) The prevention of dementia with antihypertensive treatment. New evidence from the sytolic Hypertension in Europe (Syst-Eur) Study. Arch Intern Med 162:2046-2052
22. Fried LP, Borhani NO, Enright P et al. (1991) The Cardiovascular Health study: design and rationale. Ann Epidemiol 1:263-276
23. Galassi R, Morreale A, Montagna P et al. (1991) Binswanger's disease and normal-pressure hydrozephalus: clinical and neuropsychological comparison. Arch Neurol 48:1156-1159
24. Gorelick PB (2002) Stroke prevention therapy beyond antithrombotics: unifying mechanisms in ischemic stroke pathogenesis and implications for therapy. Stroke 33:862-875
25. Guidelines Committee (2003) 2003 European Society of Hypertension/ European Society of Cardiology Guidelines for the Management of Arterial Hypertension. J Hypertens 21:1011-1054
26. Guo Z, Viitanen M, Fratiglioni L et al. (1996) Low blood pressure and dementia in elderly people: the Kungsholmen project. BMJ 312:805-808
27. Guo Z, Fratiglioni L, Zhu L et al. (1999) Occurrence and progression of dementia in a community population aged 75 years and older. Relationship of antihypertensive medication use. Arch Neurol 56:991-996
28. Gurland B, Golden RR, Teresi JA et al. (1984) The SHORT-CARE: an efficient instrument for the assessment of depression, dementia and disability. J Gerontol 39:166-169
29. Hachinski VC, Iliff LD, Zilhka E et al. (1975) Cerebral blood flow in dementia. Arch Neurol 32:632-637
30. Hachinski VC (2003) Vascular behavioral and cognitive disorders. Stroke 34:2775
31. Hagendorff A, Dettmers C, Danos P et al. (1994). Myocardial and cerebral hemodynamics during tachyarrythmia-induced hypotension in the rat. Circulation 90:400-410
32. Hansson L, Zanchetti A, Carruthers SG et al. (1998) Effects of intensive blood-pressure lowering and low-dose aspirin on patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 351:1755-1762
33. Heckbert SR, Longstreth WT Jr, Psaty BM et al. (1997) The association of antihypertensive agents with MRI white matter findings and the modified Mini-Mental State Examination in older adults. J Am Geriatr Soc 45:1423-1433
34. Honig LS, Tang MX, Albert S et al. (2003) Stroke and the risk of Alzeimer disease. Arch Neurol 60:1707-1712
35. Hughes CP, Berg L, Danziger WL et al. (1982). A new clinical scale for the staging of dementia. Br J Psychiatry 140:566-572
36. in't Veld BA, Ruitenberg A, Hofman A et al. (2001) Antihypertensive drugs and incidence of dementia: the Rotterdam Study. Neurobiol Aging 22:407-412
37. Inglis J (1959) A paired-associate learning test for use with elderly psychiatric patients. J Ment Sci 105:440-443
38. WHO (1992) International statistical classification of diseases and related health problems, 10th Rev, vol 1. WHO, Geneva
39. Kalaria RN, Skoog I (2002) Overlap with Alzheimer's disease. In: Ekinjuntti T, Gauthier S (eds) Vascular cognitive impairment. Dunitz, London, pp 145-166
40. Kaplan N (1998) J-curve not burned off by HOT study. Lancet 351:1748-1749
41. Kario K, Matsuo T, Kobayashi H et al. (1996) Nocturnal fall of blood pressure and silent cerebrovascular damage in elderly hypertensive patients: advanced silent cerebrovascular damage in extreme dippers. Hypertension 27:130-135
42. Kemper TL, Blatt GJ, Killiany RJ et al. (2001) Neuropathology of progressive cognitive decline in chronically hypertensive rhesus monkeys. Acta Neuropathol (Berl) 101:145-153
43. Kilander L, Nyman H, Boberg M et al. (1998) Hypertension is related to cognitive impairment. A 20-year follow-up of 999 men. Hypertension 31:780-786
44. Kivipelto M, Helkala EL, Laakso MP et al. (2001) Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population study. BMJ 322:1447-1451
45. Knopman DS, Parisi JE, Boeve BF et al. (2003) Vascular dementia in a population-based autopsy study. Arch Neurol 60:569-575
46. Kohara K, Jiang Y, Igase M et al. (1999) Postprandial hypotension is associated with asymptomatic cerebrovascular damage in essential hypertensive patients. Hypertension 33:565-568
47. Launer LJ, Masaki K, Petrovitch H et al. (1995) The association between midlife blood pressure levels and late-life cognitive function. The Honululu-Asia aging study. JAMA 274:1846-1851
48. Launer LJ, Ross GW, Petrovitch H et al. (2000) Midlife blood pressure and dementia: the Honululu-Asia aging study. Neurobiol Aging 21:49-55
49. Lindsay J, Laurin D, Verreault R et al. (2002) Risk factors for Alzheimer's disease: a prospective analysis from the Canadian study of health and aging. Am J Epidemiol 156:445-453
50. Lithell H, Hansson L, Skoog I et al. (2003) The study on cognition and prognosis in the elderly (SCOPE): principal results of a randomized double-blind interventional trial. J Hypertens 21:875-886
51. Lopez-Arrieta, Birks J (2002) Nimodipine for primary degenerative, mixed and vascular dementia. Cochrane Database Syst Rev.
52. Madureira S, Guerreiro M, Ferro JM (2001) Dementia and cognitive impairment three months after stroke. Eur J Neurol 8:621-627
53. Maxwell CJ, Hogan DB, Ebly EM (1999) Calcium-channel blockers and cognitive function in elderly people: results from the Canadian study of health and aging. CMAJ 161:501-506
54. Mc Khann G, Drachmann D, Folstein M et al. (1984) Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34:939-944
55. Meyer JS, Judd BW, Jawakina T et al. (1986) Improved cognition after control of risk factors for multi infarct dementia. JAMA 256:2203-2209
56. MRC Working Party (1992) Medical Research Council trial of treatment of hypertension in older adults: principal results. BMJ 304:405-412
57. Munoz DG, Hastak SM, Harper B et al. (1993) Pathologic correlates of increased signals of the centrum ovale on magnetic resonance imaging. Arch Neurol 50:492-497
58. Neuropathology Group of the Medical Research Council Cognitive Function and Aging Study (MRC CFAS) (2001) Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Lancet 357:169-175
59. O'Brien JT, Erkinjuntti T, Reisberg B et al. (2003) Vascular cognitive impairment. Lancet Neurol 2:89-98
60. Pandav R, Dodge HH, DeKosky ST et al. (2003) Blood pressure and cognitive impairment in India and the United States. A cross-national epidemiological study. Arch Neurol 60:1123-1128
61. Pantoni L, Garcia JH (1997) Pathogenesis of leukoaraiosis. A review. Stroke 28:652-659
62. Petrovitch H, White LR, Izmirilian G et al. (2000) Midlife blood pressure and neuritic plaques, neurofibrillary tangles, and brain weight at death: the HAAS. Neurobiol Aging 21:57-62
63. Phillips SJ, Whisnant JP (1992) Hypertension and the brain. Arch Intern Med 152:938-945
64. Posner HB, Tang MX, Luchsinger J et al. (2002) The relationship of hypertension in the elderly to AD, vascular dementia, and cognitive function. Neurology 58:1175-1181
65. Badrinath P, Wakeman AP, Wakeman JG (2002) Preventing stroke with ramipril - letters. BMJ 325:439-441
66. Prince MJ, Bird AS, Blizard RA et al. (1996) Is the cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the Medical Research Council's treatment trial of hypertension in older adults. BMJ 312:801-805
67. PROGRESS Collaborative Group (2001) Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 358:1033-1041
68. PROGRESS Collaborative Group (2003) Effects of blood pressure lowering with perindopril and indapamide therapy an dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med 163:1069-1075
69. Qiu C, von Strauss E, Fastbom J et al. (2003) Low blood pressure and risk of dementia in the Kungsholmen project. Arch Neurol 60:223-228
70. Román GC, Tatemichi TK, Erkinjuntti T et al. (1993) Vascular dementia: diagnostic criteria for research studies. Report on the NINDS-AIREN International Workshop. Neurology 43:250-260
71. Román GC, Erkinjuntti T, Wallin A et al. (2002) Subcortical ischemic vascular dementia. Lancet Neurol 1:426-436
72. Román GC, Royall DR (2004) A diagnostic dilemma: is "Alzheimer's dementia" Alzheimer's disease, vascular dementia, or both? Lancet Neurol 3:141
73. Ruitenberg A, Skoog I, Ott A et al. (2001) Blood pressure and risk of dementia: results from the Rotterdam Study and the Gothenburg H-70 Study. Dement Geriatr Cogn Disord 12:33-39
74. Schmidt R, Schmidt H, Fazekas F (2000) Vascular risk factors in dementia. J Neurol 247:81-87
75. Semplicini A, Maresca A, Sartori M et al. (2001) Hypertension and cerebrovascular diseases: a specific role of vascular protection for the prevention of dementia. J Cardiovasc Pharmacol 38(Suppl 2):S79-S82
76. SHEP Cooperative Research Group (1991) Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the systolic hypertension in the elderly program (SHEP). JAMA 265:3255-3264
77. Silverberg GD, Mayo M, Saul T et al. (2003) Alzheimer's disease, normal-pressure hydrocephalus, and senescent changes in CSF circulatory physiology: a hypothesis. Lancet Neurol 2:506-511
78. Skoog I, Lernfelt B, Landahl S et al. (1996) 15-year longitudinal study of blood pressure and dementia. Lancet 347:1141-1145
79. Skoog I (1997) The relationship between blood pressure and dementia: a review. Biomed Pharmacother 51:367-375
80. Sparks DL (1997) Coronary artery disease, hypertension, ApoE, and cholesterol: a link to Alzheimer's disease? Ann NY Acad Sci 826:128-146
81. Staessen JA, Wang JG, Thijs L (2003) Cardiovascular prevention and blood pressure reduction: a quantitative overview updated until 1 March 2003. J Hypertens 21:1055-1076
82. Teng EL, Chui HC (1987) The modified Mini-Mental State (3MS) examination. J Clin Psychiatry 48:314-318
83. Teng EL, Hasegawa K, Homma A et al. (1994) The Cognitive Abilities Screening Instrument (CASI): a practical test for cross-cultural epidemiological studies of dementia. Int Psychogeriatr 6:45-58
84. Tombaugh TN, McIntyre NJ (1992) The mini-mental state examination: a comprehensive review. J Am Geriatr Soc 40:922-935
85. Wade JP, Mirsen TR, Hachinski VC et al. (1987) The clinical diagnosis of Alzheimer's disease. Arch Neurol 44:24-29
86. Wallin A, Milos V, Sjögren M et al. (2002) Classification and subtypes of vascular dementia. In: Ekinjuntti T, Gauthier S (eds) Vascular cognitive impairment. Dunitz, London, pp 27-42
87. Wechsler D (1955) Manual for the Wechsler Adult Intelligence Scale. Psychological Corporation, New York
88. Wilkie F, Eisdorfer C (1971) Intelligence and blood pressure in the aged. Science 172:959-962
89. Wilkland I, Halling K, Ryden-bergsten T et al. (1997) Does lowering the blood pressure improve the mood: quality-of-life results from the Hypertension Optimal Treatment (HOT) Study. Blood Press 6:357-364